Tenaya Therapeutics (TNYA) Earnings Date & Reports
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNYA is expected to report earnings to fall 28.44% to -6 cents per share on August 12
Q2'26
Est.
$-0.06
Q1'26
Est.
$-0.09
Q4'25
Est.
$-0.12
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.04
The last earnings report on May 05 showed earnings per share of -9 cents, meeting the estimate of -9 cents. With 2.55M shares outstanding, the current market capitalization sits at 158.54M.